Press Releases from Anagnostics Bioanalysis GmbH (3 total)
Drug Development: Vela Laboratories and Anagnostics enter strategic partnershipt …
Companionship in clinical studies: patient stratification by cost-effective compact sequencing is a first step.
Affinity and Immunogenicity: hybcell as an alternative to SPR (surface plasmon resonance) technology for larger sample collectives will be tested and positioned.
Viennese Vela Laboratories are among the leading companies offering efficacy and release testing for biopharmaceuticals under GMP conditions (Good Manufacturing Practice). Vela Laboratories and Anagnostics have agreed upon a strategic partnership in the fields of…
Anagnostics and Sony DADC announce European collaboration
Sony DADC is taking charge of production of the smart consumables components of Anagnostics’ hybcell-tests. This joint development of the hybcell tests will enhance the effectiveness of the laboratory tests and advance the integration and automation of their production.
Sony DADC BioSciences is a worldwide leader in the development and production of plastic consumables and technical coatings used in medical technology. The company, based in Anif near Salzburg, is particularly successful…
Smart cancer diagnostics from Austria impresses in Italy: tecnet supports succes …
St. Pölten / St. Valentin, October 28, 2011 – A globally unique diagnostics tool for routine medical operations is now available in Italy for the first time. To this end, the Austrian company Anagnostics Bioanalysis GmbH has agreed to enter into a sales partnership with Italian Cell.ENG s.r.l. with immediate effect. The Italian company is thus being granted the rights of sale of an innovative tool for the identification of…
